Initial Public Offering (IPO)
Search documents
Factbox-Mega IPOs loom as Wall Street anticipates breakout year for listings
Yahoo Finance· 2026-02-09 16:25
Feb 9 (Reuters) - Pent-up demand for new listings and a strong pipeline of high-profile private companies such as Elon Musk's SpaceX is setting the stage for what could be a breakout year for the U.S. initial public offering market. Goldman Sachs predicted last week that proceeds from U.S. IPOs could vault to a record $160 billion in 2026, should the marquee names go public this year. Market participants are also optimistic on a bigger year for billion-dollar-plus IPOs, underpinned by a strong pipel ...
Barclays share price forms risky patterns ahead of earnings
Invezz· 2026-02-09 08:45
Core Viewpoint - Barclays share price has shown a pullback ahead of its earnings report, influenced by the Bank of England's interest rate decision and market anticipation for upcoming financial results [1] Group 1: Earnings and Financial Performance - Barclays is set to publish its earnings on Tuesday, with recent results indicating strong performance in the third quarter, where income rose to £7.2 billion and nine-month income exceeded £22.1 billion [1] - The profit before tax for the third quarter increased to £2.1 billion, with a Return on Tangible Equity (RoTE) of 10.6% [1] - The UK income rose by 16%, while the UK Corporate Bank and Private Bank and Wealth Management segments increased by 17% and 3%, respectively [1] - Analysts expect Barclays' net interest income for the upcoming results to be £3.35 billion, with other net fees at £3.18 billion, leading to an annual NII of £12.7 billion and fees over £14.4 billion [1] - The quarterly profit before tax is anticipated to be £1.32 billion, with an annual figure of £7 billion, alongside a £1 billion share buyback announcement [1] Group 2: Market and Technical Analysis - Barclays share price retreated from a year-to-date high of 505p to 480p, forming a bearish divergence pattern in technical analysis [1] - The Relative Strength Index (RSI) decreased from a high of 78 to 71, indicating potential weakness [1] - A doji candlestick pattern has formed, suggesting a common bearish reversal signal, with a risk of further retreat post-earnings [1] - The next key target for the stock price is 450p, while a move above 505p would invalidate the bearish outlook [1]
Ahead of IPO filing, Bonfiglioli Transmissions names Ravindra Pisharody as chairperson
BusinessLine· 2026-02-07 07:40
Bonfiglioli Transmissions, which is set to file its initial public offering (IPO) with markets regulator SEBI this month, has appointed Ravindra Pisharody as chairperson, people familiar with the matter said. In addition, the company has named Sundaresan Ananthanarayanan and Rossella Schiavini as Independent Directors. Bonfiglioli Transmissions, the Indian subsidiary of Italy-based Bonfiglioli Group, is a technology-driven provider of mechanical and electro-mechanical power transmission and industrial drive ...
Jennifer Garner-backed kids' food brand Once Upon a Farm rises 16% in Wall Street debut
Yahoo Finance· 2026-02-06 22:11
Company Overview - Once Upon a Farm (OFRM) stock rose 16.9% in its market debut, indicating strong investor interest amid a resurgence in IPO activity on Wall Street [1] - The company specializes in premium kids' food products, including refrigerated pouches, oat bars, protein bars, puffs, and melts, targeting children aged two to five [1] Financial Performance - In the first half of 2025, the company's sales reached $201.6 million, reflecting a 64.6% increase from 2018, driven by an expansion of product offerings and market presence [2] - The company has a significant retail presence, with major sales occurring at retailers such as Target, Whole Foods, Kroger, Walmart, and wholesale clubs like Costco [5] Product Strategy - The company is evolving its product lineup with a focus on protein, aligning with the increasing consumer demand for this macronutrient [3] - Approximately 40% of the company's ingredients are sourced from foreign suppliers, while 98% of its packaging is sourced domestically, allowing for flexibility in sourcing in response to market conditions [6] Market Context - The IPO of Once Upon a Farm coincided with other notable IPOs, such as Bob's Discount Furniture, and reflects a "reasonably steady footing" in the IPO market, with nine listings raising $2.6 billion in January [7] - The company's co-founder, John Foraker, emphasized that Once Upon a Farm is a more mature company with greater growth opportunities compared to his previous venture, Annie's [7]
Hennessy Capital Investment Corp. VIII Announces Closing of Upsized $241,500,000 Initial Public Offering
Globenewswire· 2026-02-06 21:15
Core Viewpoint - Hennessy Capital Investment Corp. VIII successfully completed its upsized initial public offering, raising gross proceeds of $241.5 million through the sale of 24,150,000 units priced at $10.00 per unit, with trading commencing on Nasdaq under the ticker symbol "HCICU" [1][2]. Group 1: IPO Details - The IPO included 3,150,000 units sold due to the full exercise of the underwriters' over-allotment option [1]. - Each unit consists of one Class A ordinary share and one right to receive one-twelfth of one Class A ordinary share upon the consummation of the Company's initial business combination [1]. - The proceeds from the IPO, amounting to $241.5 million, were placed in the Company's trust account [4]. Group 2: Company Background - The Company is a newly incorporated blank check company founded by Daniel J. Hennessy, aimed at effecting a merger, share exchange, asset acquisition, or similar business combination [2]. - The Company intends to focus its search for a target business in the industrial technology and energy transition sectors [2]. Group 3: Management and Underwriters - Daniel J. Hennessy, Chairman and CEO, expressed gratitude for investor trust and emphasized the Company's commitment to delivering long-term value [2]. - Barclays Capital Inc. and Cohen & Company Capital Markets served as the lead joint book-running managers for the IPO, with Academy Securities, Inc. as a co-book running manager [3].
Jennifer Garner's Baby Food Company—Once Upon a Farm—Is Set for an IPO Today
Investopedia· 2026-02-06 17:50
Core Insights - Once Upon a Farm, a children's food company co-founded by actress Jennifer Garner, went public today, trading on the New York Stock Exchange under the symbol "OFRM" [1] - The company raised nearly $200 million through its initial public offering (IPO) by selling approximately 11 million shares at $18 each, which is within the marketed range of $17 to $19 [1] - The IPO price gives Once Upon a Farm a market capitalization of about $724 million [1] Financial Performance - Sales for Once Upon a Farm reached $110.6 million in the first half of 2025, marking a 68% increase from $65.8 million in the same period the previous year [1] - The company reported losses of approximately $28.5 million in the first half of 2025, compared to $4.2 million in losses during the same period last year [1] - Co-founder John Foraker expressed confidence in the company's future profitability, stating that they expect to be a very profitable company soon [1] Product Offering and Market Presence - Once Upon a Farm specializes in fresh and organic baby food products, including blended produce pouches, oat bars, frozen meals, and snacks [1] - The company's products are available at major retailers such as Amazon-owned Whole Foods, Walmart, Target, Costco, and Kroger [1] - The brand's focus on fresh ingredients was inspired by Garner's personal experience of making baby food at home due to dissatisfaction with store options [1]
Bitcoin's rough week, Amazon's plunge, Super Bowl ads and more in Morning Squawk
CNBC· 2026-02-06 13:29
分组1 - Stellantis expects a $26 billion hit from a business overhaul, leading to a more than 25% drop in its U.S.-listed shares [1] - The company's stock has already decreased over 12% at the start of 2026 [1] 分组2 - Bob's Discount Furniture had its IPO priced at $17 per share, valuing the company at $2.22 billion [8] - The IPO comes at a time when traditional IPOs raised $33.6 billion in 2025, marking the best year since 2021 [8] 分组3 - Peloton shares fell more than 25% due to weak quarterly earnings and demand [9] - Estée Lauder's stock dropped over 19% after announcing a $100 million hit to full-year profitability due to tariffs [9]
Cambridge Acquisition Corp. Announces the Pricing of $200 Million Initial Public Offering
Globenewswire· 2026-02-06 12:45
Core Viewpoint - Cambridge Acquisition Corp. has successfully priced its initial public offering (IPO) of 20,000,000 units at $10.00 per unit, with each unit comprising one Class A ordinary share and one-third of a redeemable warrant [1]. Group 1: IPO Details - The IPO consists of 20,000,000 units priced at $10.00 each, with each unit including one Class A ordinary share and one-third of a redeemable warrant [1]. - Each whole warrant allows the holder to purchase one Class A ordinary share at a price of $11.50 [1]. - The units are expected to begin trading on the Nasdaq under the ticker symbol "CAQUU" starting February 6, 2026 [1]. Group 2: Underwriting and Closing - BTIG, LLC is serving as the sole book-running manager for the offering [2]. - The underwriter has a 45-day option to purchase an additional 3,000,000 units at the IPO price to cover over-allotments [2]. - The offering is anticipated to close on February 9, 2026, subject to customary closing conditions [2]. Group 3: Company Overview - Cambridge Acquisition Corp. is a special purpose acquisition company (SPAC) designed to engage in mergers, amalgamations, share exchanges, asset acquisitions, or similar business combinations with one or more businesses [5].
Agomab Announces Pricing of Initial Public Offering
Globenewswire· 2026-02-06 00:24
Core Viewpoint - Agomab Therapeutics NV has announced the pricing of its initial public offering (IPO) of 12,500,000 American Depositary Shares (ADSs) at a price of $16.00 per ADS, aiming to raise gross proceeds of $200 million before expenses [1][2]. Company Overview - Agomab is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, particularly targeting chronic fibrotic indications with high unmet medical need [6]. - The company's product candidates aim to target established pathways and utilize validated modalities to enhance efficacy while minimizing systemic toxicities, addressing limitations of previous therapeutic approaches [6]. IPO Details - The ADSs are set to begin trading on the Nasdaq Global Select Market under the ticker symbol "AGMB" on February 6, 2026, with the offering expected to close on February 9, 2026, pending customary closing conditions [2]. - J.P. Morgan, Morgan Stanley, Leerink Partners, and Van Lanschot Kempen are serving as joint book-running managers for the offering [2]. - Agomab has granted underwriters a 30-day option to purchase an additional 1,875,000 ADSs at the IPO price [1]. Regulatory Information - A registration statement for the offering was filed with the Securities and Exchange Commission and became effective on January 30, 2026, with the offering being made solely by means of a prospectus [3].
Speed(SPED) - Prospectus(update)
2026-02-05 21:55
As filed with the Securities and Exchange Commission on February 5, 2026 Registration No. 333-291316 850 Library Avenue, Suite 204 Newark, Delaware 19711 +1 302-738-6680 (Name, address, including zip code, and telephone number, including area code, of agent for service) __________________________________ Copies to: UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 1 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 __________________________________ SPEE ...